DRINKING & DRUGS DIVISION Winter 2016 _________________________________________________________________________________ 67th Annual Meeting August 11-13, 2017 Narratives in the World of Social Problems: Power, Resistance, Transformation Montreal Bonaventure Hotel Montreal, Québec Canada MESSAGE FROM THE CHAIR Dear Drinking and Drugs Division members: We are pleased to announce the publication of our Winter 2016-2017 newsletter. This edition highlights recent publications from several of our members and two news features by Division members Maryanne Alderson and Brett Wolfson-Stofko reporting from both coasts on marijuana legalization in California and Safe Injection Facilities and current initiatives in New York City, respectively. There are several important announcements that should be of interest to division members. Please feel free to distribute widely and encourage others in your networks to consider joining SSSP and the Drinking and Drugs Division. The final program for our 2017 annual meeting in Montreal will be distributed this summer. In the meantime, please see the call for papers and be sure to submit abstracts/papers no later than midnight, January 31, 2017. Best for the holidays, Alex S. Bennett, PhD Drinking and Drugs – Division Chair ANNOUNCEMENTS Graduate Student Paper Competition: Deadline 3/31/17 Please submit and spread this announcement to doctoral students in you departments to apply for the 2017 Bruce D. Johnson Student Paper Award. The First Place Winner will receive a $100 stipend and recognition at the 2017 annual meeting of the Society for the Study of Social Problems. Empirical and/or theoretical papers no longer than 30 pages in length, must present original research related to drinking and/or drugs and the entrant must have had the sole responsibility of preparing the manuscript. Students must be currently enrolled in a graduate degree program and not yet received a Ph.D., J.D. or M.D. degree at time of submission. Self-nominations are permitted. Applicants should send the paper as an attachment along with a cover letter identifying the graduate program by March 31, 2017 to: Guarino@NDRI.org Interdisciplinary Research Training Institute on Hispanic Drug Abuse (IRTI) Now Accepting Applications through January 20, 2017. The IRTI promotes the career development of pre-doctoral, post-doctoral and early career scientists interested in conducting research on drug abuse among Hispanics. The IRTI is funded by the National Institutes of Health (NIH), National Institute of Drug Abuse. Over the course of a two-year fellowship, we aim to provide a formal mentoring structure for educational training, mentoring by senior faculty members, and networking opportunities with leading experts in the field of Hispanic drug research that will increase the capacity of participants to conduct research leading to extramural funding. The IRTI ensures an infrastructure of constant support for fellows to conduct, present, publish and acquire funding for NIH research. For applications and more information please visit www.irti.usc.edu or contact Erika Smith, Program Administrator at erikague@usc.edu. Follow the Drinking and Drugs Division on Twitter Check out our Twitter account @sssp_dd for relevant news articles and sites. We will also share updates about the upcoming annual meeting. If you don’t already follow us please do! We’d love to connect with you and generate discussion while promoting awareness for social justice! 2016 MEETING OVERVIEW Congratulations to the 2016 Division Award Winners! Thank you to everyone who attended and made the conference a success. We hope to see you in 2017! Bruce D. Johnson Student Paper Award Winner: Burrel J. Vann, Ph.D. Candidate, is a Center for the Study of Democracy Peltason Fellow in the Department of Sociology at the University of California, Irvine. He is a Ford Foundation Dissertation (2016) and Predoctoral (2014) Fellow. His paper, “Structural Segregation and Marijuana Legalization,” was selected for the Bruce D. Johnson Student Paper Award. Senior Scholar Award Winner: Craig Reinarman, Ph.D., is a Professor Emeritus and Professor of Sociology and Legal Studies Emeritus in the Sociology Department at the University California, Santa Cruz. Reinarman has widely published on drug use, addiction, law, treatment and policy; with a specific focus on sociological issues surrounding crack/cocaine. Junior Scholar Award Winner: Luther Elliott, Ph.D. is a Principal Investigator at the National Development and Research Institutes, Inc. A trained cultural and research anthropologist his research focus is on pathways to substance use and behavioral addictions. He is currently serving as project director and co-investigator on a study of overdose risks and prevention strategies for military veterans. CALL FOR PAPERS DRINKING AND DRUGS DIVISION SPONSORED SESSIONS Session # Session Title Sponsor(s) Organizer(s) 5 Non-Academic Jobs and How To Get Them 1. Community Research and Development 2. Disability 3. Drinking and Drugs 1. Steinberg, Hillary R. hillary.steinberg@colorado.edu 35 CRITICAL DIALOGUE: Self-Care and Therapeutic Use of Drugs-THEMATIC 1. Drinking and Drugs 1. Perrone, Dina dina.perrone@csulb.edu 36 PAPERS IN THE ROUND: Drinking and Drugs 1. Drinking and Drugs 1. Benoit, Ellen benoit@ndri.org 37 Intersectional Identities and Drug Use-THEMATIC 1. Drinking and Drugs 1. Nowotny, Kathryn M. Kathryn.Nowotny@Miami.edu 2. Kavanaugh, Philip R. prk114@psu.edu 38 Overdose: Context, Venues, and Policy 1. Drinking and Drugs 2. Health, Health Policy, and Health Services 1. Guarino, Honoria guarino@ndri.org39 Evolving Narratives on Cannabis Use, Law and Policy 1. Drinking and Drugs 2. Law and Society 1. Roddy, Juliette jroddy@umich.edu40 Narratives of Oppression and Resistance in the Context of Substance Use- THEMATIC 1. Drinking and Drugs 2. Social Problems Theory 1. Benoit, Ellen benoit@ndri.org 2. Lamonica, Aukje K. aukje_kluge@yahoo.com 41 Drugs and Mental Health 1. Drinking and Drugs 2. Society and Mental Health 1. Furst, Terry TFURST3334@AOL.COM42 Pharmacological Co-production of Health, Well-being, and the Body 1. Drinking and Drugs 2. Sport, Leisure, and the Body 1. Elliott, Luther elliott@ndri.org 2. Ford, Jason A. Jason.Ford@ucf.edu RECENT PUBLICATIONS BY DRINKING AND DRUGS DIVISION MEMBERS Interpersonal attacks on the dignity of members of HIV key populations: A descriptive and exploratory study. Friedman, Samuel R; Pouget, Enrique R, Sandoval, Milagros; Rossi, Diana; Mateu-Gelabert, Pedro; Nikolopoulos, Georgios K; Schneider, John A; Smyrnov, Pavlo; Stall, Ron D. AIDS & Behavior, in press. NIHMSID 823756 "Not human, dead already": Perceptions and experiences of drug-related stigma among opioid-using young adults from the former Soviet Union living in New York City. Gunn, Alana and Guarino, Honoria (2016). International Journal of Drug Policy, 38: 63-72. Heroin Use and Injection Risk Behaviors in Colombia: Implications for HIV/AIDS Prevention. Pedro Mateu-Gelabert, Shana Harris, Dedsy Berbesi, Ángela María Segura Cardona, Liliana Patricia Montoya Vélez, Inés Elvira Mejía Motta, Lauren Jessell, Honoria Guarino & Samuel R. Friedman (2016): Substance Use & Misuse, DOI: 10.3109/10826084.2015.1092989: pp 230-240 To link to this article: http://dx.doi.org/10.3109/10826084.2015.1092989 The portapotty experiment: Neoliberal approaches to the intertwined epidemics of opioid-related overdose and HIV/HCV, and why we need cultural anthropologists in the South Bronx. Wolfson-Stofko, B., Curtis, R., Fuentes, F., Manchess, E., Rio-Cumba, A.D., Bennett, A.S. (2016). Dialectical Anthropology, DOI 10.1007/s10624-016-9443-4 Drug use in business bathrooms: An exploratory study of manager encounters in New York City. Wolfson-Stofko, B., Bennett, A.S., Elliott, L., Curtis, R. (2017). International Journal of Drug Policy, 39, 69-77. The 13th edition of Drugs and Society (Burlington, MA: Jones and Bartlett Learning) will be released in January 2017. This text is coauthored by Glen R., Hanson, Peter J. Venturelli, and Annette E. Fleckenstein FEATURED WORK The Quest for Supervised Injection Facilities in New York and Beyond Brett Wolfson-Stofko, PhD., New York University The overdose epidemic across the US and in New York City shows no sign of slowing. Data released by the New York City Department of Health and Mental Hygiene shows that drug overdose deaths have increased for the past five years in NYC, claiming 937 lives in 2015. Increasingly, street heroin and counterfeit pills have been cut with fentanyl and other potent opioid analogues, placing countless lives at risk. In these uncertain times, research suggests that lives can be saved with a common sense but controversial intervention known as supervised injection facilities (SIF) (also known as safer consumption spaces, drug consumption rooms, etc.). Supervised injection facilities have been meeting the need of active users around the world for the past 30 years and their efficacy has been proven through evidence-based studies. These facilities cater specifically to people actively using drugs in order to prevent overdose deaths and reduce the spread of disease. They are operated by medical professionals and people-in-recovery, who are able to reverse an overdose if one occurs and also ensure that no one shares needles or any other drug paraphernalia. These sites also offer counseling and link people to detox, treatment, and housing. Importantly, these facilities do not increase youth or community drug use or lead to an increase in drug-related crime. They are also cost effective so taxpayers actually save money when SIF are operational. In late-2016, the New York City Council allocated $100,000 to the city’s health department to study the feasibility of operating SIF in the city. These funds will be utilized by New York City Department of Health and Mental Hygiene (DOHMH) along with other city departments to begin addressing key issues such as insurance, liability, and legality of SIF operation. In addition, researchers at New York Academy of Medicine (NYAM) recently received a grant from New York Community Trust to conduct focus groups with key stakeholders including people who inject drugs, syringe exchange program staff, and business and community board members in order to determine the best course of action and document any concerns. Others and myself have been sub-contracted by NYAM to assist in designing, organizing and conducting these focus groups which will complement the findings of DOHMH. The anticipated release date of this report is slated for Summer 2017. The momentum for SIF is building in other cities across the country such as Seattle, Ithaca, San Francisco, Baltimore and Boston as constituents sternly demand a humane and effective response to opioid epidemic. Though it is encouraging to see that the majority of New York City Council members understand the role of SIF in addressing this overdose epidemic, the lives of people who inject drugs will continue to be jeopardized until these facilities are operational. FEATURED WORK Recreational Marijuana Now Legal in CA Maryanne Alderson, California State University, Long Beach In 1996, California was the first state to legalize medical marijuana under the Compassionate Use Act. Despite this profound step forward in drug policy, California voters struggled to legalize recreational marijuana for two decades. In 2010, Proposition 19, also referred to as the Regulate, Control, and Tax Cannabis Act, was placed on the ballot in California and ultimately struck down with 53.5% voting against it. With this most recent election, California finally became 1 of 8 states to legalize recreational marijuana use for adults, passing the Adult Use of Marijuana Act (AUMA) with 57.13% of the vote. The Adult Use of Marijuana Act legalizes the recreational use of marijuana for adults at least 21 years of age. AUMA legalizes the possession, sale, and transport of marijuana within CA. This act also contains sentencing and criminal justice reform, eliminating and reducing all marijuana penalties, preventing minors from being incarcerated for marijuana, and will ultimately be applied retroactively. AUMA creates a 15% retail tax for marijuana sales, exempting medical marijuana patients. Drug Policy Alliance proposes an annual revenue of $1 billion. This revenue is then allocated to California public universities for legalization research, California Highway Patrol to establish DUI protocols, UC San Diego Center for Medicinal Cannabis Research, youth drug treatment, and a community reinvestment fund for those disproportionately affected by the drug war. AUMA was primarily written and endorsed by Drug Policy Alliance, and received several other endorsements, including the California Democratic Party, ACLU of California, Law Enforcement Against Prohibition, Los Angeles Community Health Project, Youth Justice Coalition, and Lt. Governor Gavin Newsom. Despite the wide support from both individuals and agencies, AUMA was the subject of criticism and controversy. Concern spread regarding how AUMA will affect medical marijuana patients and clinics. AUMA does exempt medical marijuana patients from the sales tax and protects medical marijuana clinics through a separate licensing process. Several critics expressed concern about AUMA’s lack of protection against big business and big pharma. Although AUMA contains a non-commercial clause, this clause only bans big business licenses for sale for the first five years. It does not protect small farmers and cultivators and will no longer protect small business owners after it expires. Lastly, the revenue allocation cannot be changed. Once AUMA was passed, the funding allocation directives will remain in effect. AUMA will go into effect January 1, 2017. As we have seen wide success for marijuana legalization in states like Colorado and Washington, researchers and critics will need to wait and see what lies ahead for marijuana use, cultivation, and sale in California, to truly assess the impact and ultimate success or failure of the Adult Use of Marijuana Act. We look forward to seeing you in Montreal!